Allen Edwin Buhl

Title: Allen Edwin Buhl: Innovator in Amyloid-Related Research

Introduction

Allen Edwin Buhl is a notable inventor based in Portage, MI (US), recognized for his contributions to the field of amyloid-related conditions. He holds a total of 4 patents, showcasing his innovative approach to diagnosing and treating complex medical issues.

Latest Patents

Buhl's latest patents include significant advancements in the diagnosis and treatment of amyloid-related conditions. One of his inventions focuses on compounds and methods for diagnosing and treating these conditions. This invention provides methods for detecting, imaging, monitoring, diagnosing, and treating conditions characterized by the binding or aggregation of amyloid fibrils. More specifically, it relates to the use of quinolinehydrazone compounds for these purposes, as well as their application as antioxidants. Another notable patent involves a method for identifying compounds that modulate the interaction of amyloid beta or its aggregates with a voltage-gated sodium channel. This invention offers assays and methods for diagnosing and treating diseases, such as Alzheimer's disease, based on the interaction between amyloid beta and the sodium channel.

Career Highlights

Throughout his career, Allen Edwin Buhl has worked with prominent companies, including The Upjohn Company and Pharmacia & Upjohn Company. His work in these organizations has contributed to his expertise and innovative capabilities in the field of medical research.

Collaborations

Buhl has collaborated with esteemed colleagues, including Arthur R. Diani and Heinrich Josef Schostarez. These partnerships have likely enhanced his research and development efforts in the medical field.

Conclusion

Allen Edwin Buhl's contributions to the understanding and treatment of amyloid-related conditions highlight his innovative spirit and dedication to medical research. His patents reflect a commitment to advancing healthcare solutions and improving patient outcomes.